The Discounted Cash Flow (DCF) valuation of Genomed SA (GEN.WA) is 21.17 PLN. With the latest stock price at 25.80 PLN, the upside of Genomed SA based on DCF is -17.9%.

Is GEN.WA a buy or a sell?

Based on the latest price of 25.80 PLN and our DCF valuation, Genomed SA (GEN.WA) is a sell. Selling GEN.WA stocks now will result in a potential gain of 17.9%.

	Range	Selected
WACC / Discount Rate	6.2% - 7.2%	6.7%
Long-term Growth Rate	1.0% - 3.0%	2.0%
Fair Price	17.43 - 28.48	21.17
Upside	-32.4% - 10.4%	-17.9%

25.80 PLN

Stock Price

21.17 PLN

Fair Price

REVENUE & EXPENSES

CAPEX

D&A

WORKING CAPITAL

TERMINAL VALUE

GEN.WA DCF Valuation: Revenue & Expenses Forecast

(PLN in millions)		Projections

	12-2024	12-2025	12-2026	12-2027	12-2028	12-2029

Revenue	23	24	25	27	28	29
% Growth	2%	5%	4%	6%	5%	4%

Cost of goods sold	(13)	(13)	(14)	(15)	(15)	(16)
% of Revenue	55%	55%	55%	55%	55%	55%

Selling, G&A expenses	(8)	(8)	(8)	(9)	(9)	(10)
% of Revenue	34%	34%	34%	34%	34%	34%

Research & Development	0	0	0	0	0	0
% of Revenue	0%	0%	0%	0%	0%	0%

Net interest & other expenses	(1)	(1)	(2)	(2)	(2)	(2)
% of Revenue	6%	6%	6%	6%	6%	6%

Tax expense	(0)	(0)	(0)	(0)	(0)	(0)
Tax rate	9%	8%	8%	8%	8%	8%

Net profit	1	1	1	1	1	1
% Margin	5%	5%	5%	5%	5%	5%